miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis

The in-stent restenosis (IRS) after the percutaneous coronary intervention contributes to the major treatment failure of stent implantation. MicroRNAs have been revealed as powerful gene medicine to regulate endothelial cells (EC) and smooth muscle cells (SMC) in response to vascular injury, providi...

Full description

Bibliographic Details
Main Authors:	Jing Wang, Hong-Lin Qian, Sheng-Yu Chen, Wei-Pin Huang, Dan-Ni Huang, Hong-Ye Hao, Ke-Feng Ren, Yun-Bing Wang, Guo-Sheng Fu, Jian Ji
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2021-12-01
Series:	Bioactive Materials
Subjects:	microRNA Spongy coating Biodegradable stent Contractile phenotype Restenosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452199X21002139

Similar Items

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
by: Francesco Condello, et al.
Published: (2023-02-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
by: Jae-Chan Ryu, et al.
Published: (2023-02-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Hypersensitivity and in-stent restenosis in coronary stent materials
by: Wansong Hu, et al.
Published: (2022-09-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
by: Kakhaber Etsadashvili, et al.
Published: (2011-06-01)

Stentys self-apposing stents in the treatment of in-stent restenosis - A friend or a foe?
by: Baskar Sekar, et al.
Published: (2021-01-01)

Usefulness of optical coherence tomography imaging for diagnosis of in-stent restenosis due to a stent fracture and morphological assessment
by: Yusuke Oba, et al.
Published: (2019-03-01)

Novel A20-gene-eluting stent inhibits carotid artery restenosis in a porcine model
by: Zhou ZH, et al.
Published: (2016-08-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
by: Hasan Shemirani, et al.
Published: (2011-09-01)

The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting
by: Hajizadeh Reza, et al.
Published: (2017-12-01)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
by: Yu-Ling Hsu, et al.
Published: (2023-07-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
by: Hongfei Xi, et al.
Published: (2023-03-01)

In-stent restenosis and longitudinal stent deformation: a case report
by: Daoyuan Si, et al.
Published: (2020-01-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
by: Xiaohang Yuan, et al.
Published: (2023-08-01)

Gene Delivery from Stents for Prevention of In Stent Restenosis
by: Ilia Fishbein, et al.
Published: (2016-12-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

In-stent restenosis. Acute and long-term outcomes after excimer laser coronary angioplasty
by: Jorge Bejarano, et al.
Published: (1999-08-01)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
by: Emrah Erdogan, et al.
Published: (2022-11-01)

Evaluation of Femoropopliteal In-Stent Restenosis Characteristics Stratified by Stent Design
by: Elias Noory, et al.
Published: (2023-11-01)

Association Between Atherogenic Index of Plasma and Atherogenic Coefficient and in-Stent Restenosis After Drug-eluting Stent Implantation for Stable Coronary Artery Disease
by: Yasin Yüksel, et al.
Published: (2023-02-01)

Comparison of Neoatherosclerosis and Neovascularization of Restenosis after Drug-Eluting Stent Implantation: An Optical Coherence Tomography Study
by: Chancui Deng, et al.
Published: (2023-11-01)

Progress of In-stent Restenosis after Vertebral Artery Ostium Stenosis and Imaging Assessments
by: Jingzhi Li, MD, John R. Eisenbrey, PhD, Yang Hua, MD
Published: (2018-08-01)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

In Stent Restenosis After Carotid Artery Stenting From Diagnosis to Treatment
by: Giuseppe Di Gioia, et al.
Published: (2016-08-01)

Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation
by: Zheng Qin, et al.
Published: (2017-01-01)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
by: Yong Zhu, et al.
Published: (2021-12-01)

5 year-effectiveness of paclitaxel drug-eluting balloon for coronary in-stent restenosis in a real-world registry
by: José Antonio Linares Vicente, et al.
Published: (2019-05-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

The Predictive Value of the CHA2DS2-VASc Score for In-Stent Restenosis Among Patients with Drug-Eluting Stents Implantation
by: Zhao J, et al.
Published: (2023-01-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
by: Yong Zhu, et al.
Published: (2021-07-01)

Vertebral artery stenting: problem of restenosis
by: A. O. Chechetkin
Published: (2017-02-01)